Biologics Congress Europe – Slide release
Posted 6th June 2018 by Jane Williams
Presented at the 4th Biologics & Biosimilars Congress, these free slides are now available to download and share with your colleagues.
Strategies for Coping with the Evolving Landscape of Biosimilars Patent Resolution in the United States
 |
The United States passed the Biologics Price Competition and Innovation Act (“BPCIA”) in 2009 to bring biosimilar drug products to market. Here Andrew W. Williams from McDonnell Boehnen Hulbert & Berghoff discusses patent issues, price competition and provides guidelines for biosimilar applicants.
 |
The Journey to “The” Antibody: Accessing a Versatile Toolbox
 |
Triple Vector allows work to flow straightforward from research directly into mammalian expression in full therapeutic format eliminating the need to change the backbone of the plasmid thus saving much time and money.
|
Global Legal Issues Associated with Biosimilars
 |
This presentation focuses on: The current state of biosimilars globally, regulatory issues, patent challenges faced by companies, ways to minimize risk and high level review of patent litigation worldwide.
|
Want to read more on Biologics? Why not click here to see our latest blog post?
Leave a Reply